Abstract
An improved method for the synthesis of (6'R)-6'-C-methylneplanocin A (RMNPA, 2), a potent S-adenosyl-L-homocysteine (AdoHcy) hydrolase inhibitor, was developed via a chelation-controlled stereoselective addition of MeTiCl(3) to the neplanocin A 6'-aldehyde derivative 6. Compound 2 effectively inhibited the growth of malaria parasites both in vitro and in vivo. The antimalarial EC(50) value of 2 against Plasmodium berghei in mice was 1.0 mg/kg/day, which was superior to that of chloroquine (EC(50) = 1.8 mg/kg/day).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine / analogs & derivatives
-
Adenosine / chemical synthesis*
-
Adenosine / chemistry
-
Adenosine / pharmacology
-
Adenosylhomocysteinase
-
Animals
-
Antimalarials / chemical synthesis*
-
Antimalarials / chemistry
-
Antimalarials / pharmacology
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Hydrolases / antagonists & inhibitors*
-
Malaria / drug therapy
-
Mice
-
Plasmodium berghei
-
Plasmodium falciparum / drug effects
Substances
-
Antimalarials
-
Enzyme Inhibitors
-
6'-C-methylneplanocin A
-
Hydrolases
-
Adenosylhomocysteinase
-
Adenosine